Link copied
By Reuters
(Reuters) - Eli Lilly said on Tuesday it would buy Centessa Pharmaceuticals in a deal worth about $6.3 billion to advance treatments for sleep-wake disorders.
(Reporting by Sneha S K)
This week on Reuters
Dwindling central bank support for Indian rupee, bonds spooks markets
How investors buy gold and what fuels the market
Foreign outflows hit Asian stocks as Iran war drives oil shock fears